查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1866691

無血清培養基：全球市場佔有率和排名、總收入和需求預測（2025-2031年）

Serum-Free Media - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球無血清培養基市場預計在 2024 年達到 14.64 億美元，預計到 2031 年將達到 31.4 億美元，2025 年至 2031 年的複合年成長率為 11.4%。

本報告對近期與無血清培養基相關的關稅調整和國際戰略反制措施進行了全面評估，包括其對跨境產業佈局、資本配置模式、區域經濟相互依存關係和供應鏈重組的影響。

無血清培養基 (SFM) 是一種不含動物血清的細胞培養基，專為體外培養哺乳動物、昆蟲、幹細胞及其他類型的細胞而設計。與添加牛(FBS) 的傳統培養基不同，SFM 提供精確配比的氨基酸、維生素、無機鹽、激素、生長因子和微量元素，為細胞生長創造穩定且可重複的環境，同時消除了血清帶來的變異性和潛在病原體風險。由於其高標準和可控性，SFM 已成為生物製藥、細胞和基因治療、疫苗研發、單株抗體生產以及大規模工業細胞培養的核心原料。近年來，在細胞治療和重組蛋白藥物快速發展的推動下，SFM 市場已從實驗室應用轉向工業規模應用，在生物製藥價值鏈中佔據了重要的戰略地位。 2024年，全球無血清培養基產量達到約3,450萬公升，全球平均市場價格約為每公升42.43美元。

全球生物製藥產業的持續擴張以及對創新藥物研發投入的不斷增加，正推動無血清培養基（SFM）市場強勁成長。細胞療法、基因編輯、疫苗生產和CAR-T療法等先進治療方法的商業化，正推動對高品質、可追溯、不含動物源成分的培養系統的需求激增，加速從含血清培養基向無血清培養基的過渡。監管機構（FDA、EMA、NMPA）持續提升產品均一性和安全性標準，進一步凸顯了SFM的策略重要性。賽默飛世爾科技（Thermo Fisher）、Cytiva和默克集團（Merck KGaA）等全球領導者正在拓展其SFM產品線，而歐普邁（OpM）、賽默飛世爾中國和無錫艾普泰等中國企業則大力投資研發和生產能力。隨著技術障礙的不斷提高，市場整合程度日益加劇。政策支持和資本投資也在推動市場成長，預計未來五年複合年成長率將超過10%。儘管SFM市場成長迅速，但仍面臨許多挑戰，包括複雜的配方開發、高昂的生產成本以及標準化難度。不同類型的細胞需要高度專業的培養環境，因此需要大量的研發和檢驗。同時，關鍵原料（例如重組生長因子和非動物性蛋白質）價格依然昂貴，這給早期研發階段的價格帶來了壓力。來自擁有強大品牌知名度和先進技術的全球領導企業的激烈競爭，為新興企業設置了很高的進入門檻。監管機構對產品品質一致性和供應鏈透明度的審查日益嚴格，這要求企業在品管和生產技術方面進行大量投資。此外，對集中於美國和歐洲的原料供應鏈的依賴也對市場穩定性構成風險。 SFM的需求正在多元化發展，並轉向更高附加價值的下游製程。隨著細胞和基因療法進入臨床和商業化階段，製藥公司和合約研發生產機構（CDMO）正在擴大高性能SFM的採購，從而促進從研究級到工業規模生產的過渡。疫苗生產商和蛋白質藥物研發企業正在採用超流式細胞儀（SFM）來提高產品的安全性、均一性和批間可靠性。類器官、3D細胞培養、合成生物學和體外診斷等新興領域正在拓展超流式細胞儀的應用範圍。隨著法規結構和品質系統的日益完善，籌資策略正轉向全球供應鏈和長期夥伴關係，這為主要企業提供了成長機遇，也為小型企業提供了創新主導的差異化發展空間。

本報告旨在對全球無血清培養基市場進行全面分析，重點關注總銷售量、收入、價格、市場佔有率和主要企業的排名，並按地區/國家、類型和應用對無血清培養基進行分析。

本報告以2024年為基準年，按銷售量（千升）和收入（百萬美元）對無血清培養基市場規模、估算和預測進行了闡述，並涵蓋了2020年至2031年的歷史數據和預測數據。報告提供了定量和定性分析，旨在幫助讀者制定業務和成長策略，評估市場競爭，分析自身在當前市場中的地位，並就無血清培養基做出明智的商業決策。

市場區隔

公司

  • Thermo Fisher Scientific
  • Merck
  • Corning
  • Cytiva
  • Lonza
  • Fujifilm
  • HiMedia Laboratories
  • Takara
  • Kohjin Bio
  • Sartorius
  • Stemcell Technologies
  • Jianshun Biosicences
  • OPM Biosciences
  • Yocon
  • Sino Biological
  • Basal Media
  • Duoning Bio
  • Bio-engine
  • Bio-Rad
  • Bio-Techne

按類型分類的細分市場

  • 哺乳動物細胞培養基
  • 幹細胞培養基
  • 昆蟲細胞培養基
  • 其他

應用領域

  • 生物製藥生產
  • 調查
  • 其他

按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Serum-Free Media was estimated to be worth US$ 1464 million in 2024 and is forecast to a readjusted size of US$ 3140 million by 2031 with a CAGR of 11.4% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Serum-Free Media cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Serum-Free Media (SFM) is a class of cell culture media designed without the use of animal serum, intended for in vitro cultivation of mammalian, insect, stem, and other cell types. Unlike traditional media supplemented with fetal bovine serum (FBS), SFM offers a precisely formulated composition of amino acids, vitamins, inorganic salts, hormones, growth factors, and trace elements, providing a stable and reproducible environment for cell growth while eliminating the variability and potential pathogen risks associated with serum. Its high standardization and controllability make SFM a core material in biopharmaceuticals, cell and gene therapy, vaccine development, monoclonal antibody production, and large-scale industrial cell culture. In recent years, driven by the rapid growth of cell therapy and recombinant protein drugs, the SFM market has shifted from laboratory use to industrial-scale applications, establishing itself as a strategically critical link in the biopharmaceutical value chain.In 2024, global Serum-Free Media production reached approximately 34.5 million L, with an average global market price of around US$ 42.43 per L.

The global biopharmaceutical industry's continuous expansion and increased investment in innovative drug R&D have created strong momentum for the serum-free media (SFM) market. The commercialization of advanced therapies such as cell therapy, gene editing, vaccine manufacturing, and CAR-T is driving a surge in demand for high-quality, traceable, and animal-component-free culture systems, accelerating the shift from serum-based media to SFM. Regulatory agencies (FDA, EMA, NMPA) are raising standards for product consistency and safety, further highlighting the strategic importance of SFM. Global leaders like Thermo Fisher, Cytiva, and Merck KGaA are expanding their SFM portfolios, while Chinese companies such as OpM, Thermo Fisher China, and WuXi AppTec are investing heavily in R&D and production capacity. The market is becoming increasingly consolidated, with growing technical barriers. Policy support and capital investment are also fueling market growth, with a projected CAGR of over 10% in the next five years.Despite rapid growth, the SFM market faces multiple challenges, including complex formulation development, high production costs, and difficulties in standardization. Different cell types require highly specialized environments, demanding extensive R&D and validation, while key raw materials (such as recombinant growth factors and animal-free proteins) remain costly, creating pricing pressures for early-stage adoption. Intense competition from global leaders with strong brand recognition and advanced technology creates high entry barriers for emerging players. Regulatory scrutiny on quality consistency and supply chain transparency is increasing, requiring significant investments in quality management and production technologies. Moreover, reliance on highly concentrated raw material supply chains in the US and Europe poses risks to market stability.Downstream demand for SFM is becoming more diversified and high-value-driven. With cell and gene therapies advancing into clinical and commercial phases, pharmaceutical companies and CDMOs are increasing their procurement of high-performance SFM, driving a shift from research-grade to industrial-scale production. Vaccine manufacturers and protein drug developers are adopting SFM to enhance product safety, consistency, and batch-to-batch reliability. Emerging fields such as organoids, 3D cell culture, synthetic biology, and in vitro diagnostics are expanding SFM's application scope. As regulatory frameworks and quality systems mature, purchasing strategies are moving toward globalized supply chains and long-term partnerships, providing growth opportunities for leading companies and innovation-driven differentiation for smaller players.

This report aims to provide a comprehensive presentation of the global market for Serum-Free Media, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Serum-Free Media by region & country, by Type, and by Application.

The Serum-Free Media market size, estimations, and forecasts are provided in terms of sales volume (K L) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Serum-Free Media.

Market Segmentation

By Company

  • Thermo Fisher Scientific
  • Merck
  • Corning
  • Cytiva
  • Lonza
  • Fujifilm
  • HiMedia Laboratories
  • Takara
  • Kohjin Bio
  • Sartorius
  • Stemcell Technologies
  • Jianshun Biosicences
  • OPM Biosciences
  • Yocon
  • Sino Biological
  • Basal Media
  • Duoning Bio
  • Bio-engine
  • Bio-Rad
  • Bio-Techne

Segment by Type

  • Mammalian Cell Culture Media
  • Stem Cell Culture Media
  • Insect Cell Culture Media
  • Other

Segment by Application

  • Biopharmaceutical Manufacturing
  • Research
  • Other

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Serum-Free Media manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Serum-Free Media in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Serum-Free Media in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Serum-Free Media Product Introduction
  • 1.2 Global Serum-Free Media Market Size Forecast
    • 1.2.1 Global Serum-Free Media Sales Value (2020-2031)
    • 1.2.2 Global Serum-Free Media Sales Volume (2020-2031)
    • 1.2.3 Global Serum-Free Media Sales Price (2020-2031)
  • 1.3 Serum-Free Media Market Trends & Drivers
    • 1.3.1 Serum-Free Media Industry Trends
    • 1.3.2 Serum-Free Media Market Drivers & Opportunity
    • 1.3.3 Serum-Free Media Market Challenges
    • 1.3.4 Serum-Free Media Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Serum-Free Media Players Revenue Ranking (2024)
  • 2.2 Global Serum-Free Media Revenue by Company (2020-2025)
  • 2.3 Global Serum-Free Media Players Sales Volume Ranking (2024)
  • 2.4 Global Serum-Free Media Sales Volume by Company Players (2020-2025)
  • 2.5 Global Serum-Free Media Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Serum-Free Media Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Serum-Free Media Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Serum-Free Media
  • 2.9 Serum-Free Media Market Competitive Analysis
    • 2.9.1 Serum-Free Media Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Serum-Free Media Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Serum-Free Media as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Mammalian Cell Culture Media
    • 3.1.2 Stem Cell Culture Media
    • 3.1.3 Insect Cell Culture Media
    • 3.1.4 Other
  • 3.2 Global Serum-Free Media Sales Value by Type
    • 3.2.1 Global Serum-Free Media Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Serum-Free Media Sales Value, by Type (2020-2031)
    • 3.2.3 Global Serum-Free Media Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Serum-Free Media Sales Volume by Type
    • 3.3.1 Global Serum-Free Media Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Serum-Free Media Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Serum-Free Media Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Serum-Free Media Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Biopharmaceutical Manufacturing
    • 4.1.2 Research
    • 4.1.3 Other
  • 4.2 Global Serum-Free Media Sales Value by Application
    • 4.2.1 Global Serum-Free Media Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Serum-Free Media Sales Value, by Application (2020-2031)
    • 4.2.3 Global Serum-Free Media Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Serum-Free Media Sales Volume by Application
    • 4.3.1 Global Serum-Free Media Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Serum-Free Media Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Serum-Free Media Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Serum-Free Media Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Serum-Free Media Sales Value by Region
    • 5.1.1 Global Serum-Free Media Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Serum-Free Media Sales Value by Region (2020-2025)
    • 5.1.3 Global Serum-Free Media Sales Value by Region (2026-2031)
    • 5.1.4 Global Serum-Free Media Sales Value by Region (%), (2020-2031)
  • 5.2 Global Serum-Free Media Sales Volume by Region
    • 5.2.1 Global Serum-Free Media Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Serum-Free Media Sales Volume by Region (2020-2025)
    • 5.2.3 Global Serum-Free Media Sales Volume by Region (2026-2031)
    • 5.2.4 Global Serum-Free Media Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Serum-Free Media Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Serum-Free Media Sales Value, 2020-2031
    • 5.4.2 North America Serum-Free Media Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Serum-Free Media Sales Value, 2020-2031
    • 5.5.2 Europe Serum-Free Media Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Serum-Free Media Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Serum-Free Media Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Serum-Free Media Sales Value, 2020-2031
    • 5.7.2 South America Serum-Free Media Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Serum-Free Media Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Serum-Free Media Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Serum-Free Media Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Serum-Free Media Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Serum-Free Media Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Serum-Free Media Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Serum-Free Media Sales Value, 2020-2031
    • 6.3.2 United States Serum-Free Media Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Serum-Free Media Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Serum-Free Media Sales Value, 2020-2031
    • 6.4.2 Europe Serum-Free Media Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Serum-Free Media Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Serum-Free Media Sales Value, 2020-2031
    • 6.5.2 China Serum-Free Media Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Serum-Free Media Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Serum-Free Media Sales Value, 2020-2031
    • 6.6.2 Japan Serum-Free Media Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Serum-Free Media Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Serum-Free Media Sales Value, 2020-2031
    • 6.7.2 South Korea Serum-Free Media Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Serum-Free Media Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Serum-Free Media Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Serum-Free Media Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Serum-Free Media Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Serum-Free Media Sales Value, 2020-2031
    • 6.9.2 India Serum-Free Media Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Serum-Free Media Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Thermo Fisher Scientific
    • 7.1.1 Thermo Fisher Scientific Company Information
    • 7.1.2 Thermo Fisher Scientific Introduction and Business Overview
    • 7.1.3 Thermo Fisher Scientific Serum-Free Media Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Thermo Fisher Scientific Serum-Free Media Product Offerings
    • 7.1.5 Thermo Fisher Scientific Recent Development
  • 7.2 Merck
    • 7.2.1 Merck Company Information
    • 7.2.2 Merck Introduction and Business Overview
    • 7.2.3 Merck Serum-Free Media Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Merck Serum-Free Media Product Offerings
    • 7.2.5 Merck Recent Development
  • 7.3 Corning
    • 7.3.1 Corning Company Information
    • 7.3.2 Corning Introduction and Business Overview
    • 7.3.3 Corning Serum-Free Media Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Corning Serum-Free Media Product Offerings
    • 7.3.5 Corning Recent Development
  • 7.4 Cytiva
    • 7.4.1 Cytiva Company Information
    • 7.4.2 Cytiva Introduction and Business Overview
    • 7.4.3 Cytiva Serum-Free Media Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Cytiva Serum-Free Media Product Offerings
    • 7.4.5 Cytiva Recent Development
  • 7.5 Lonza
    • 7.5.1 Lonza Company Information
    • 7.5.2 Lonza Introduction and Business Overview
    • 7.5.3 Lonza Serum-Free Media Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Lonza Serum-Free Media Product Offerings
    • 7.5.5 Lonza Recent Development
  • 7.6 Fujifilm
    • 7.6.1 Fujifilm Company Information
    • 7.6.2 Fujifilm Introduction and Business Overview
    • 7.6.3 Fujifilm Serum-Free Media Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Fujifilm Serum-Free Media Product Offerings
    • 7.6.5 Fujifilm Recent Development
  • 7.7 HiMedia Laboratories
    • 7.7.1 HiMedia Laboratories Company Information
    • 7.7.2 HiMedia Laboratories Introduction and Business Overview
    • 7.7.3 HiMedia Laboratories Serum-Free Media Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 HiMedia Laboratories Serum-Free Media Product Offerings
    • 7.7.5 HiMedia Laboratories Recent Development
  • 7.8 Takara
    • 7.8.1 Takara Company Information
    • 7.8.2 Takara Introduction and Business Overview
    • 7.8.3 Takara Serum-Free Media Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Takara Serum-Free Media Product Offerings
    • 7.8.5 Takara Recent Development
  • 7.9 Kohjin Bio
    • 7.9.1 Kohjin Bio Company Information
    • 7.9.2 Kohjin Bio Introduction and Business Overview
    • 7.9.3 Kohjin Bio Serum-Free Media Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 Kohjin Bio Serum-Free Media Product Offerings
    • 7.9.5 Kohjin Bio Recent Development
  • 7.10 Sartorius
    • 7.10.1 Sartorius Company Information
    • 7.10.2 Sartorius Introduction and Business Overview
    • 7.10.3 Sartorius Serum-Free Media Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 Sartorius Serum-Free Media Product Offerings
    • 7.10.5 Sartorius Recent Development
  • 7.11 Stemcell Technologies
    • 7.11.1 Stemcell Technologies Company Information
    • 7.11.2 Stemcell Technologies Introduction and Business Overview
    • 7.11.3 Stemcell Technologies Serum-Free Media Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 Stemcell Technologies Serum-Free Media Product Offerings
    • 7.11.5 Stemcell Technologies Recent Development
  • 7.12 Jianshun Biosicences
    • 7.12.1 Jianshun Biosicences Company Information
    • 7.12.2 Jianshun Biosicences Introduction and Business Overview
    • 7.12.3 Jianshun Biosicences Serum-Free Media Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 Jianshun Biosicences Serum-Free Media Product Offerings
    • 7.12.5 Jianshun Biosicences Recent Development
  • 7.13 OPM Biosciences
    • 7.13.1 OPM Biosciences Company Information
    • 7.13.2 OPM Biosciences Introduction and Business Overview
    • 7.13.3 OPM Biosciences Serum-Free Media Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.13.4 OPM Biosciences Serum-Free Media Product Offerings
    • 7.13.5 OPM Biosciences Recent Development
  • 7.14 Yocon
    • 7.14.1 Yocon Company Information
    • 7.14.2 Yocon Introduction and Business Overview
    • 7.14.3 Yocon Serum-Free Media Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.14.4 Yocon Serum-Free Media Product Offerings
    • 7.14.5 Yocon Recent Development
  • 7.15 Sino Biological
    • 7.15.1 Sino Biological Company Information
    • 7.15.2 Sino Biological Introduction and Business Overview
    • 7.15.3 Sino Biological Serum-Free Media Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.15.4 Sino Biological Serum-Free Media Product Offerings
    • 7.15.5 Sino Biological Recent Development
  • 7.16 Basal Media
    • 7.16.1 Basal Media Company Information
    • 7.16.2 Basal Media Introduction and Business Overview
    • 7.16.3 Basal Media Serum-Free Media Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.16.4 Basal Media Serum-Free Media Product Offerings
    • 7.16.5 Basal Media Recent Development
  • 7.17 Duoning Bio
    • 7.17.1 Duoning Bio Company Information
    • 7.17.2 Duoning Bio Introduction and Business Overview
    • 7.17.3 Duoning Bio Serum-Free Media Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.17.4 Duoning Bio Serum-Free Media Product Offerings
    • 7.17.5 Duoning Bio Recent Development
  • 7.18 Bio-engine
    • 7.18.1 Bio-engine Company Information
    • 7.18.2 Bio-engine Introduction and Business Overview
    • 7.18.3 Bio-engine Serum-Free Media Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.18.4 Bio-engine Serum-Free Media Product Offerings
    • 7.18.5 Bio-engine Recent Development
  • 7.19 Bio-Rad
    • 7.19.1 Bio-Rad Company Information
    • 7.19.2 Bio-Rad Introduction and Business Overview
    • 7.19.3 Bio-Rad Serum-Free Media Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.19.4 Bio-Rad Serum-Free Media Product Offerings
    • 7.19.5 Bio-Rad Recent Development
  • 7.20 Bio-Techne
    • 7.20.1 Bio-Techne Company Information
    • 7.20.2 Bio-Techne Introduction and Business Overview
    • 7.20.3 Bio-Techne Serum-Free Media Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.20.4 Bio-Techne Serum-Free Media Product Offerings
    • 7.20.5 Bio-Techne Recent Development

8 Industry Chain Analysis

  • 8.1 Serum-Free Media Industrial Chain
  • 8.2 Serum-Free Media Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Serum-Free Media Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Serum-Free Media Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Serum-Free Media Market Trends
  • Table 2. Serum-Free Media Market Drivers & Opportunity
  • Table 3. Serum-Free Media Market Challenges
  • Table 4. Serum-Free Media Market Restraints
  • Table 5. Global Serum-Free Media Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Serum-Free Media Revenue Market Share by Company (2020-2025)
  • Table 7. Global Serum-Free Media Sales Volume by Company (2020-2025) & (K L)
  • Table 8. Global Serum-Free Media Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Serum-Free Media Price by Company (2020-2025) & (US$/L)
  • Table 10. Key Manufacturers Serum-Free Media Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Serum-Free Media Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Serum-Free Media
  • Table 13. Global Serum-Free Media Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Serum-Free Media as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Serum-Free Media Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Serum-Free Media Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Serum-Free Media Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Serum-Free Media Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Serum-Free Media Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Serum-Free Media Sales Volume by Type: 2020 VS 2024 VS 2031 (K L)
  • Table 22. Global Serum-Free Media Sales Volume by Type (2020-2025) & (K L)
  • Table 23. Global Serum-Free Media Sales Volume by Type (2026-2031) & (K L)
  • Table 24. Global Serum-Free Media Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Serum-Free Media Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Serum-Free Media Price by Type (2020-2025) & (US$/L)
  • Table 27. Global Serum-Free Media Price by Type (2026-2031) & (US$/L)
  • Table 28. Global Serum-Free Media Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Serum-Free Media Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Serum-Free Media Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Serum-Free Media Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Serum-Free Media Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Serum-Free Media Sales Volume by Application: 2020 VS 2024 VS 2031 (K L)
  • Table 34. Global Serum-Free Media Sales Volume by Application (2020-2025) & (K L)
  • Table 35. Global Serum-Free Media Sales Volume by Application (2026-2031) & (K L)
  • Table 36. Global Serum-Free Media Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Serum-Free Media Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Serum-Free Media Price by Application (2020-2025) & (US$/L)
  • Table 39. Global Serum-Free Media Price by Application (2026-2031) & (US$/L)
  • Table 40. Global Serum-Free Media Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Serum-Free Media Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Serum-Free Media Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Serum-Free Media Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Serum-Free Media Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Serum-Free Media Sales Volume by Region (K L): 2020 VS 2024 VS 2031
  • Table 46. Global Serum-Free Media Sales Volume by Region (2020-2025) & (K L)
  • Table 47. Global Serum-Free Media Sales Volume by Region (2026-2031) & (K L)
  • Table 48. Global Serum-Free Media Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Serum-Free Media Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Serum-Free Media Average Price by Region (2020-2025) & (US$/L)
  • Table 51. Global Serum-Free Media Average Price by Region (2026-2031) & (US$/L)
  • Table 52. Key Countries/Regions Serum-Free Media Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Serum-Free Media Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Serum-Free Media Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Serum-Free Media Sales Volume, (2020-2025) & (K L)
  • Table 56. Key Countries/Regions Serum-Free Media Sales Volume, (2026-2031) & (K L)
  • Table 57. Thermo Fisher Scientific Company Information
  • Table 58. Thermo Fisher Scientific Introduction and Business Overview
  • Table 59. Thermo Fisher Scientific Serum-Free Media Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
  • Table 60. Thermo Fisher Scientific Serum-Free Media Product Offerings
  • Table 61. Thermo Fisher Scientific Recent Development
  • Table 62. Merck Company Information
  • Table 63. Merck Introduction and Business Overview
  • Table 64. Merck Serum-Free Media Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
  • Table 65. Merck Serum-Free Media Product Offerings
  • Table 66. Merck Recent Development
  • Table 67. Corning Company Information
  • Table 68. Corning Introduction and Business Overview
  • Table 69. Corning Serum-Free Media Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
  • Table 70. Corning Serum-Free Media Product Offerings
  • Table 71. Corning Recent Development
  • Table 72. Cytiva Company Information
  • Table 73. Cytiva Introduction and Business Overview
  • Table 74. Cytiva Serum-Free Media Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
  • Table 75. Cytiva Serum-Free Media Product Offerings
  • Table 76. Cytiva Recent Development
  • Table 77. Lonza Company Information
  • Table 78. Lonza Introduction and Business Overview
  • Table 79. Lonza Serum-Free Media Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
  • Table 80. Lonza Serum-Free Media Product Offerings
  • Table 81. Lonza Recent Development
  • Table 82. Fujifilm Company Information
  • Table 83. Fujifilm Introduction and Business Overview
  • Table 84. Fujifilm Serum-Free Media Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
  • Table 85. Fujifilm Serum-Free Media Product Offerings
  • Table 86. Fujifilm Recent Development
  • Table 87. HiMedia Laboratories Company Information
  • Table 88. HiMedia Laboratories Introduction and Business Overview
  • Table 89. HiMedia Laboratories Serum-Free Media Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
  • Table 90. HiMedia Laboratories Serum-Free Media Product Offerings
  • Table 91. HiMedia Laboratories Recent Development
  • Table 92. Takara Company Information
  • Table 93. Takara Introduction and Business Overview
  • Table 94. Takara Serum-Free Media Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
  • Table 95. Takara Serum-Free Media Product Offerings
  • Table 96. Takara Recent Development
  • Table 97. Kohjin Bio Company Information
  • Table 98. Kohjin Bio Introduction and Business Overview
  • Table 99. Kohjin Bio Serum-Free Media Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
  • Table 100. Kohjin Bio Serum-Free Media Product Offerings
  • Table 101. Kohjin Bio Recent Development
  • Table 102. Sartorius Company Information
  • Table 103. Sartorius Introduction and Business Overview
  • Table 104. Sartorius Serum-Free Media Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
  • Table 105. Sartorius Serum-Free Media Product Offerings
  • Table 106. Sartorius Recent Development
  • Table 107. Stemcell Technologies Company Information
  • Table 108. Stemcell Technologies Introduction and Business Overview
  • Table 109. Stemcell Technologies Serum-Free Media Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
  • Table 110. Stemcell Technologies Serum-Free Media Product Offerings
  • Table 111. Stemcell Technologies Recent Development
  • Table 112. Jianshun Biosicences Company Information
  • Table 113. Jianshun Biosicences Introduction and Business Overview
  • Table 114. Jianshun Biosicences Serum-Free Media Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
  • Table 115. Jianshun Biosicences Serum-Free Media Product Offerings
  • Table 116. Jianshun Biosicences Recent Development
  • Table 117. OPM Biosciences Company Information
  • Table 118. OPM Biosciences Introduction and Business Overview
  • Table 119. OPM Biosciences Serum-Free Media Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
  • Table 120. OPM Biosciences Serum-Free Media Product Offerings
  • Table 121. OPM Biosciences Recent Development
  • Table 122. Yocon Company Information
  • Table 123. Yocon Introduction and Business Overview
  • Table 124. Yocon Serum-Free Media Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
  • Table 125. Yocon Serum-Free Media Product Offerings
  • Table 126. Yocon Recent Development
  • Table 127. Sino Biological Company Information
  • Table 128. Sino Biological Introduction and Business Overview
  • Table 129. Sino Biological Serum-Free Media Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
  • Table 130. Sino Biological Serum-Free Media Product Offerings
  • Table 131. Sino Biological Recent Development
  • Table 132. Basal Media Company Information
  • Table 133. Basal Media Introduction and Business Overview
  • Table 134. Basal Media Serum-Free Media Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
  • Table 135. Basal Media Serum-Free Media Product Offerings
  • Table 136. Basal Media Recent Development
  • Table 137. Duoning Bio Company Information
  • Table 138. Duoning Bio Introduction and Business Overview
  • Table 139. Duoning Bio Serum-Free Media Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
  • Table 140. Duoning Bio Serum-Free Media Product Offerings
  • Table 141. Duoning Bio Recent Development
  • Table 142. Bio-engine Company Information
  • Table 143. Bio-engine Introduction and Business Overview
  • Table 144. Bio-engine Serum-Free Media Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
  • Table 145. Bio-engine Serum-Free Media Product Offerings
  • Table 146. Bio-engine Recent Development
  • Table 147. Bio-Rad Company Information
  • Table 148. Bio-Rad Introduction and Business Overview
  • Table 149. Bio-Rad Serum-Free Media Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
  • Table 150. Bio-Rad Serum-Free Media Product Offerings
  • Table 151. Bio-Rad Recent Development
  • Table 152. Bio-Techne Company Information
  • Table 153. Bio-Techne Introduction and Business Overview
  • Table 154. Bio-Techne Serum-Free Media Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
  • Table 155. Bio-Techne Serum-Free Media Product Offerings
  • Table 156. Bio-Techne Recent Development
  • Table 157. Key Raw Materials Lists
  • Table 158. Raw Materials Key Suppliers Lists
  • Table 159. Serum-Free Media Downstream Customers
  • Table 160. Serum-Free Media Distributors List
  • Table 161. Research Programs/Design for This Report
  • Table 162. Key Data Information from Secondary Sources
  • Table 163. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Serum-Free Media Product Picture
  • Figure 2. Global Serum-Free Media Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Serum-Free Media Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Serum-Free Media Sales Volume (2020-2031) & (K L)
  • Figure 5. Global Serum-Free Media Sales Price (2020-2031) & (US$/L)
  • Figure 6. Serum-Free Media Report Years Considered
  • Figure 7. Global Serum-Free Media Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Serum-Free Media Players Sales Volume Ranking (2024) & (K L)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Serum-Free Media Revenue in 2024
  • Figure 10. Serum-Free Media Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Mammalian Cell Culture Media Picture
  • Figure 12. Stem Cell Culture Media Picture
  • Figure 13. Insect Cell Culture Media Picture
  • Figure 14. Other Picture
  • Figure 15. Global Serum-Free Media Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 16. Global Serum-Free Media Sales Value Market Share by Type, 2024 & 2031
  • Figure 17. Global Serum-Free Media Sales Volume by Type (2020 VS 2024 VS 2031) & (K L)
  • Figure 18. Global Serum-Free Media Sales Volume Market Share by Type, 2024 & 2031
  • Figure 19. Global Serum-Free Media Price by Type (2020-2031) & (US$/L)
  • Figure 20. Product Picture of Biopharmaceutical Manufacturing
  • Figure 21. Product Picture of Research
  • Figure 22. Product Picture of Other
  • Figure 23. Global Serum-Free Media Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 24. Global Serum-Free Media Sales Value Market Share by Application, 2024 & 2031
  • Figure 25. Global Serum-Free Media Sales Volume by Application (2020 VS 2024 VS 2031) & (K L)
  • Figure 26. Global Serum-Free Media Sales Volume Market Share by Application, 2024 & 2031
  • Figure 27. Global Serum-Free Media Price by Application (2020-2031) & (US$/L)
  • Figure 28. North America Serum-Free Media Sales Value (2020-2031) & (US$ Million)
  • Figure 29. North America Serum-Free Media Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Europe Serum-Free Media Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Europe Serum-Free Media Sales Value by Country (%), 2024 VS 2031
  • Figure 32. Asia Pacific Serum-Free Media Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. Asia Pacific Serum-Free Media Sales Value by Region (%), 2024 VS 2031
  • Figure 34. South America Serum-Free Media Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. South America Serum-Free Media Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Middle East & Africa Serum-Free Media Sales Value, (2020-2031) & (US$ Million)
  • Figure 37. Middle East & Africa Serum-Free Media Sales Value by Country (%), 2024 VS 2031
  • Figure 38. Key Countries/Regions Serum-Free Media Sales Value (%), (2020-2031)
  • Figure 39. Key Countries/Regions Serum-Free Media Sales Volume (%), (2020-2031)
  • Figure 40. United States Serum-Free Media Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. United States Serum-Free Media Sales Value by Type (%), 2024 VS 2031
  • Figure 42. United States Serum-Free Media Sales Value by Application (%), 2024 VS 2031
  • Figure 43. Europe Serum-Free Media Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. Europe Serum-Free Media Sales Value by Type (%), 2024 VS 2031
  • Figure 45. Europe Serum-Free Media Sales Value by Application (%), 2024 VS 2031
  • Figure 46. China Serum-Free Media Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. China Serum-Free Media Sales Value by Type (%), 2024 VS 2031
  • Figure 48. China Serum-Free Media Sales Value by Application (%), 2024 VS 2031
  • Figure 49. Japan Serum-Free Media Sales Value, (2020-2031) & (US$ Million)
  • Figure 50. Japan Serum-Free Media Sales Value by Type (%), 2024 VS 2031
  • Figure 51. Japan Serum-Free Media Sales Value by Application (%), 2024 VS 2031
  • Figure 52. South Korea Serum-Free Media Sales Value, (2020-2031) & (US$ Million)
  • Figure 53. South Korea Serum-Free Media Sales Value by Type (%), 2024 VS 2031
  • Figure 54. South Korea Serum-Free Media Sales Value by Application (%), 2024 VS 2031
  • Figure 55. Southeast Asia Serum-Free Media Sales Value, (2020-2031) & (US$ Million)
  • Figure 56. Southeast Asia Serum-Free Media Sales Value by Type (%), 2024 VS 2031
  • Figure 57. Southeast Asia Serum-Free Media Sales Value by Application (%), 2024 VS 2031
  • Figure 58. India Serum-Free Media Sales Value, (2020-2031) & (US$ Million)
  • Figure 59. India Serum-Free Media Sales Value by Type (%), 2024 VS 2031
  • Figure 60. India Serum-Free Media Sales Value by Application (%), 2024 VS 2031
  • Figure 61. Serum-Free Media Industrial Chain
  • Figure 62. Serum-Free Media Manufacturing Cost Structure
  • Figure 63. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 64. Bottom-up and Top-down Approaches for This Report
  • Figure 65. Data Triangulation
  • Figure 66. Key Executives Interviewed